These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22137461)

  • 1. The association between self-disorders and neurocognitive dysfunction in schizophrenia.
    Haug E; Øie M; Melle I; Andreassen OA; Raballo A; Bratlien U; Lien L; Møller P
    Schizophr Res; 2012 Mar; 135(1-3):79-83. PubMed ID: 22137461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verbal memory intrusions in schizophrenia: associations with self-reflectivity, symptomatology, and neurocognition.
    Fridberg DJ; Brenner A; Lysaker PH
    Psychiatry Res; 2010 Aug; 179(1):6-11. PubMed ID: 20638729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What are the neurocognitive correlates of basic self-disturbance in schizophrenia?: Integrating phenomenology and neurocognition. Part 1 (Source monitoring deficits).
    Nelson B; Whitford TJ; Lavoie S; Sass LA
    Schizophr Res; 2014 Jan; 152(1):12-9. PubMed ID: 23810736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metacognition within narratives of schizophrenia: associations with multiple domains of neurocognition.
    Lysaker PH; Dimaggio G; Buck KD; Carcione A; Nicolò G
    Schizophr Res; 2007 Jul; 93(1-3):278-87. PubMed ID: 17407806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of metacognition with symptoms, insight, and neurocognition in clinically stable outpatients with schizophrenia.
    Nicolò G; Dimaggio G; Popolo R; Carcione A; Procacci M; Hamm J; Buck KD; Pompili E; Buccione I; Lagrotteria B; Lysaker PH
    J Nerv Ment Dis; 2012 Jul; 200(7):644-7. PubMed ID: 22759945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive deficits or stress overload: Why do individuals with schizophrenia show poor performance in neurocognitive tests?
    Krkovic K; Moritz S; Lincoln TM
    Schizophr Res; 2017 May; 183():151-156. PubMed ID: 27838097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive insight and objective cognitive functioning in schizophrenia.
    Burton CZ; Harvey PD; Patterson TL; Twamley EW
    Schizophr Res; 2016 Mar; 171(1-3):131-6. PubMed ID: 26811232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.
    Ringen PA; Melle I; Berg AO; Agartz I; Spigset O; Simonsen C; Sundet K; Andreassen OA
    Schizophr Res; 2013 Jan; 143(1):84-9. PubMed ID: 23178107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness of cognitive impairment in schizophrenia and its relationship to insight into illness.
    González-Suárez B; Gomar JJ; Pousa E; Ortiz-Gil J; García A; Salvador R; Sans-Sansa B; Pomarol-Clotet E; McKenna PJ
    Schizophr Res; 2011 Dec; 133(1-3):187-92. PubMed ID: 21945548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis.
    Ayesa-Arriola R; Pérez-Iglesias R; Rodríguez-Sánchez JM; Pardo-García G; Tabares-Seisdedos R; Ayuso-Mateos JL; Vázquez-Barquero JL; Crespo-Facorro B
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():23-8. PubMed ID: 23228461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients.
    Meiron O; Hermesh H; Katz N; Weizman A
    Psychiatry Res; 2013 Aug; 209(1):1-8. PubMed ID: 23102537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallized verbal skills in schizophrenia: relationship to neurocognition, symptoms, and functional status.
    Kurtz MM; Donato J; Rose J
    Neuropsychology; 2011 Nov; 25(6):784-791. PubMed ID: 21928906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a more parsimonious assessment of neurocognition in schizophrenia: a 10-minute assessment tool.
    Fervaha G; Agid O; Foussias G; Remington G
    J Psychiatr Res; 2014 May; 52():50-6. PubMed ID: 24507885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomalous self-experiences contribute independently to social dysfunction in the early phases of schizophrenia and psychotic bipolar disorder.
    Haug E; Øie M; Andreassen OA; Bratlien U; Raballo A; Nelson B; Møller P; Melle I
    Compr Psychiatry; 2014 Apr; 55(3):475-82. PubMed ID: 24378241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the neurocognitive correlates of basic self-disturbance in schizophrenia? Integrating phenomenology and neurocognition: Part 2 (aberrant salience).
    Nelson B; Whitford TJ; Lavoie S; Sass LA
    Schizophr Res; 2014 Jan; 152(1):20-7. PubMed ID: 23863772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonoetic awareness associated with the projection of the self into the future: an investigation in schizophrenia.
    de Oliveira H; Cuervo-Lombard C; Salamé P; Danion JM
    Psychiatry Res; 2009 Aug; 169(1):86-7. PubMed ID: 19616311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.